ArticlemedRxiv : the preprint server for health sciences2024
Central role of glycosylation processes in human genetic susceptibility to SARS-CoV-2 infections with Omicron variants.
Abstract readPreprint
In one paragraph
Article in medRxiv : the preprint server for health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
44 authors.
Frank GellerDepartment of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.ORCID 0000-0002-9238-3269
Xiaoping WuDepartment of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
Vilma LammiInstitute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
Erik AbnerEstonian Genome Center, Institute of Genomics, University of Tartu, Tartu, Estonia.
Jesse Tyler ValliereCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
Katerina NastouDepartment of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
Morten RasmussenVirus Research and Development Laboratory, Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
Niklas Worm AnderssonDepartment of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
Liam QuinnDepartment of Clinical Immunology, Zealand University Hospital, Køge, Denmark.
DBDS Genomic Consortium
Bitten AagaardDepartment of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark.
Karina BanasikDepartment of Obstetrics and Gynecology, Copenhagen University Hospital, Amager & Hvidovre Hospital, Copenhagen, Denmark.
Sofie BliddalDepartment of Obstetrics and Gynecology, Copenhagen University Hospital, Amager & Hvidovre Hospital, Copenhagen, Denmark.
Lasse BodingDanish National Biobank, Statens Serum Institut, Copenhagen, Denmark.
Søren BrunakNovo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Nanna BrønsDepartment of Clinical Immunology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Jonas Bybjerg-GrauholmDepartment for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.
Lea Arregui Nordahl ChristoffersenDepartment of Clinical Immunology, Zealand University Hospital, Køge, Denmark.
Maria DidriksenDepartment of Clinical Immunology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Khoa Manh DinhDepartment of Clinical Immunology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Christian ErikstrupDepartment of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.
Ulla Feldt-RasmussenDepartment of Nephrology and Endocrinology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Kirsten GrønbækDepartment of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Kathrine Agergård KaspersenDepartment of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.
Christina MikkelsenDepartment of Clinical Immunology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Claus Henrik NielsenInstitute for Inflammation Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Henriette Svarre NielsenDepartment of Obstetrics and Gynecology, Copenhagen University Hospital, Amager & Hvidovre Hospital, Copenhagen, Denmark.
Susanne Dam NielsenViro-Immunology Research Unit, Department of Infectious Diseases, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Janna NissenDepartment of Clinical Immunology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Celia Burgos SequerosNovo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Niels TommerupDepartment of Cellular and Molecular Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Henrik UllumStatens Serum Institut, Copenhagen, Denmark.
Estonian Biobank Research Team
FinnGenDepartment of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
Lampros SpiliopoulosDepartment of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
Peter BagerDepartment of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
Anders HviidDepartment of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
Erik SørensenDepartment of Clinical Immunology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Ole Birger PedersenDepartment of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Jacqueline M LaneCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
Ria LassaunièreVirus Research and Development Laboratory, Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
Hanna M OllilaInstitute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
Sisse Rye OstrowskiDepartment of Clinical Immunology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Bjarke FeenstraDepartment of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
Funding
Leveraging human genetics to overcome complex diagnostic challenges, evaluation of pan-ancestry polygenic scores to reduce misdiagnosis of narcolepsy and circadian rhythm sleep wake disorders.R01HG012810 · NHGRI · BRIGHAM AND WOMEN'S HOSPITAL · PI Daniel J Gottlieb · 2023 to 2026
$2.6MLong COVID as a putative subtype of chronic fatigue syndromeR01AI170850 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Richa Saxena · 2022 to 2026
$2.2MGenetics of human circadian rhythms: using sequencing, novel phenotyping methods, and functional assays to move towards a deeper understanding of circadian mechanismsR35GM146839 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI LANE, JACQUELINE MARIE · 2022 to 2025
$1.8MNHGRI NIH HHS R01 HG012810NIAID NIH HHS R01 AI170850NIGMS NIH HHS R35 GM146839
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.